Exposure in Epigenetic Regulation of Immune Response in Chronic Beryllium Disease (CBD)
Clinical trial NCT02604693 · COMPLETED
Trial details
- NCT number
- NCT02604693
- Sponsor
- National Jewish Health
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2014-12-14
- Primary completion
- 2020-12-31
- Enrollment
- 148
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.